A granulation formulation of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide or pharmaceutically acceptable salt thereof, which is adapted for reconstitution with an aqueous vehicle, and associated oral suspension.
申请公布号
EP2773204(A4)
申请公布日期
2015.05.27
申请号
EP20120844715
申请日期
2012.10.16
申请人
GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED
发明人
GOSSETS AUGUSTUS , CAMPBELL;RICHARDSON, HELEN;WILLIAMS, PETER, A.
